Lisanti Capital Growth Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Patterson-UTI
PTEN
|
+$7.67M |
| 2 |
Modine Manufacturing
MOD
|
+$7.01M |
| 3 |
Fabrinet
FN
|
+$6.18M |
| 4 |
Matador Resources
MTDR
|
+$6.17M |
| 5 |
GRDN
Guardian Pharmacy Services
GRDN
|
+$6.15M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Huron Consulting
HURN
|
+$7.88M |
| 2 |
Alphatec Holdings
ATEC
|
+$7.84M |
| 3 |
Transmedics
TMDX
|
+$6.9M |
| 4 |
Lumentum
LITE
|
+$6.52M |
| 5 |
NewAmsterdam Pharma
NAMS
|
+$6.29M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 29.97% |
| 2 | Healthcare | 23.49% |
| 3 | Technology | 23.12% |
| 4 | Consumer Discretionary | 10.52% |
| 5 | Energy | 7.64% |
No holdings matched the selected filter criteria.
Similar funds
Lisanti Capital Growth's Q1 2026 Portfolio in Review
As of Q1 2026, Lisanti Capital Growth held 154 positions worth $397M, down 6% from $422M the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Lisanti Capital Growth withdrew a net $55M in Q1 2026, closing 51 positions and reducing 38 holdings. Its most notable exit was Huron Consulting, an estimated $7.88M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 30% of assets, up from 30% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Lisanti Capital Growth opened a new position in Patterson-UTI worth $9.71M.
- Lisanti Capital Growth's largest Q1 2026 buy was Patterson-UTI: 896,470 shares worth $9.71M.
- Lisanti Capital Growth added most to Waystar Holding Corp in Q1 2026, an estimated $4.57M increase.
- Lisanti Capital Growth's biggest Q1 2026 reduction was Lumentum, cutting an estimated $6.52M.
- Lisanti Capital Growth fully exited Huron Consulting in Q1 2026, selling an estimated $7.88M.
- Lisanti Capital Growth's ten largest holdings make up 21% of its $397M portfolio in Q1 2026.
- Lisanti Capital Growth opened 44 new positions and closed 51 in Q1 2026.
- Lisanti Capital Growth's portfolio value fell 6% quarter-over-quarter to $397M.
Based on Lisanti Capital Growth's 13F filing for Q1 2026, filed 7 May 2026.